Literature DB >> 7207207

Exogenous estrogens attenuate dietary hypercholesterolemia and atherosclerosis in the rabbit.

R S Kushwaha, W R Hazzard.   

Abstract

The effect of exogenous estrogens upon the response to dietary cholesterol was tested in New Zealand White rabbits. Cholesterol-fed, untreated rabbits had a 10-fold increase in plasma cholesterol in 12 wk. The major increase of cholesterol occurred in very low density lipoproteins (VLDL, 43.5-fold) followed by intermediate density lipoproteins (IDL, 26-fold) and low density lipoproteins (LDL, 6-fold) with no change in high density lipoproteins (HDL). These diet induced changes were markedly attenuated in the estrogen treated animals, in whom plasma cholesterol increased only 5-fold. This increase was distributed among LDL (6-fold), IDL (7.5-fold), and VLDL (9-fold), similarly with no change in HDL. All the lipoproteins in both groups of animals were considerably enriched in cholesterol during cholesterol feeding as indicated by a high cholesterol/protein and cholesterol/triglyceride ration. However, these ratios were lower in estrogen treated animals. There were no differences in the feed consumption, body weight or cholesterol absorption between the two groups of animals. Rabbits fed a cholesterol-rich diet but not treated with estrogen had well developed lesions in all parts of the aorta with higher content of cholesterol and phospholipids as compared to those injected with estrogen, whose aortas were completely clear of visible atherosclerosis. Equivalent total hypercholesterolemia was induced in other estrogen-treated rabbits by feeding twice the cholesterol dietary content (0.2%) as in nonestrogen-treated animals. Aortic atherosclerosis was far more evident in the latter, which had higher proportions of cholesterol-rich lipoproteins of d less than 1.006 g/ml.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7207207     DOI: 10.1016/0026-0495(81)90116-5

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  11 in total

1.  Significant reduction of the antiatherogenic effect of estrogen by long-term inhibition of nitric oxide synthesis in cholesterol-clamped rabbits.

Authors:  P Holm; N Korsgaard; M Shalmi; H L Andersen; P Hougaard; S O Skouby; S Stender
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

2.  Reduction of atherosclerosis by administration of dehydroepiandrosterone. A study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury.

Authors:  G B Gordon; D E Bush; H F Weisman
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

3.  Effect of acute and long-term treatment with 17-beta-estradiol on the vasomotor responses in the rat aorta.

Authors:  H L Andersen; J U Weis; B Fjalland; N Korsgaard
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

4.  Estrogen in patients with prostatic cancer. An assessment of the risks and benefits.

Authors:  P Henriksson
Journal:  Drug Saf       Date:  1991 Jan-Feb       Impact factor: 5.606

5.  Cellular and subcellular distribution of 125I-labeled very low density lipoproteins in the liver of normal and estrogen-treated rabbits.

Authors:  R V Iozzo; R S Kushwaha; T N Wight; W R Hazzard
Journal:  Am J Pathol       Date:  1982-04       Impact factor: 4.307

6.  Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits.

Authors:  J Haarbo; P Leth-Espensen; S Stender; C Christiansen
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

Review 7.  Androgen receptor (AR) in cardiovascular diseases.

Authors:  Chiung-Kuei Huang; Soo Ok Lee; Eugene Chang; Haiyan Pang; Chawnshang Chang
Journal:  J Endocrinol       Date:  2016-01-14       Impact factor: 4.286

8.  Longitudinal assessment of the effects of oestrogen on blood pressure and cardiovascular autonomic activity in female rats.

Authors:  Mahmoud M El-Mas; Abdel A Abdel-Rahman
Journal:  Clin Exp Pharmacol Physiol       Date:  2009-04-27       Impact factor: 2.557

9.  Protection by oestradiol against the development of cardiovascular changes associated with monocrotaline pulmonary hypertension in rats.

Authors:  M Y Farhat; M F Chen; T Bhatti; A Iqbal; S Cathapermal; P W Ramwell
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

10.  Changes in plasma lipids, lipoproteins, triglyceride secretion and removal in chicks with estrogen implants.

Authors:  J R Park; B H Cho
Journal:  Lipids       Date:  1988-04       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.